Investigating the impact of Alzheimer's disease during the COVID-19 pandemic
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
This study is looking at how the COVID-19 pandemic impacts people with Alzheimer's disease, especially regarding their health risks and outcomes based on race and gender, while also checking if COVID-19 might lead to new cases of Alzheimer's in survivors, all by analyzing health records from many patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11212181 on NIH RePORTER |
What this research studies
This research examines how the COVID-19 pandemic affects patients with Alzheimer's disease (AD), focusing on risks, outcomes, and disparities based on race and gender. It also looks at the potential for new cases of AD in individuals who have survived COVID-19. The study will analyze a large database of electronic health records from millions of patients to track these changes over time. Additionally, it will explore the effects of specific treatments on patients with both COVID-19 and AD.
Who could benefit from this research
Good fit: Ideal candidates for this research include seniors aged 65 and older, particularly those with a diagnosis of Alzheimer's disease or those who have survived COVID-19.
Not a fit: Patients who are younger than 65 or do not have Alzheimer's disease or a history of COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with Alzheimer's disease affected by COVID-19.
How similar studies have performed: Other research has shown promising results in understanding the interactions between infectious diseases and chronic conditions like Alzheimer's, making this approach both relevant and timely.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Xu, Rong — Case Western Reserve University
- Study coordinator: Xu, Rong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.